11 results
8-K
EX-1.1
SYRS
Syros Pharmaceuticals Inc.
19 Dec 23
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:59pm
Technology for Economic and Clinical Health Act (collectively, “HIPAA”) and the European Union General Data Protection Regulation (“GDPR”) collectively
8-K
EX-1.1
SYRS
Syros Pharmaceuticals Inc.
20 Jan 21
Syros Announces Proposed Offering of Common Stock
4:04pm
and Clinical Health Act (collectively, “HIPAA”) and the European Union General Data Protection Regulation (“GDPR”) collectively, the “Privacy Laws
8-K
EX-1.1
ibhs38dn
8 Apr 19
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.2
b7kohdb9maf9jv0fjms
8 Apr 19
Entry into a Material Definitive Agreement
12:00am
424B3
vb7r gr56
8 Aug 22
Prospectus supplement
5:47pm
S-4
399esm
18 Jul 22
Registration of securities issued in business combination transactions
7:58am
- Prev
- 1
- Next